Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001641172-25-019728
Filing Date
2025-07-15
Accepted
2025-07-15 16:22:47
Documents
1
Period of Report
2025-07-11

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4111
  Complete submission text file 0001641172-25-019728.txt   5573
Mailing Address 1517 SAN JACINTO HOUSTON TX 77002
Business Address
SAPIRSTEIN JAMES (Reporting) CIK: 0001559509 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41184 | Film No.: 251125045

Mailing Address 217 W. MAIN STREET SOMERVILLE NJ 08876
Business Address 217 W. MAIN STREET SOMERVILLE NJ 08876 908-370-5102
ZyVersa Therapeutics, Inc. (Issuer) CIK: 0001859007 (see all company filings)

EIN.: 862685744 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)